22
Views
2
CrossRef citations to date
0
Altmetric
Drug Profile

Pharmacoeconomic benefits of almotriptan in the acute treatment of migraine

Pages 105-110 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fabio Antonaci, Ilaria De Cillis, Maria Giovanna Cuzzoni & Marta Allena. (2010) Almotriptan for the treatment of acute migraine: a review of early intervention trials. Expert Review of Neurotherapeutics 10:3, pages 351-364.
Read now

Articles from other publishers (1)

John Slof. (2012) Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the ‘Act when Mild’ Study. Applied Health Economics and Health Policy 10:3, pages 201-215.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.